LYMPHOPROLIFERATIVE SYNDROME 2
|
disease |
|
Disease or Syndrome
|
3
|
5
|
0.720 |
strong |
0.750 |
4 |
4
|
2012 |
2017 |
B-CELL MALIGNANCY, LOW-GRADE
|
disease |
|
Neoplastic Process
|
350
|
19
|
0.020 |
None |
1.000 |
2 |
|
1998 |
1999 |
Adult Acute Lymphocytic Leukemia
|
disease |
|
Neoplastic Process
|
860
|
154
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Overweight and obesity
|
disease |
|
Disease or Syndrome
|
81
|
29
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
EBV viremia
|
disease |
|
Disease or Syndrome
|
7
|
1
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
HIV-1 infection
|
disease |
|
Disease or Syndrome
|
695
|
94
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Clinically isolated syndrome
|
disease |
|
Disease or Syndrome
|
54
|
2
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
IMMUNODEFICIENCY 13
|
disease |
|
Disease or Syndrome
|
22
|
1
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Human immunodeficiency virus (HIV) II infection category B1
|
disease |
|
Disease or Syndrome
|
985
|
56
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Advanced lung cancer
|
disease |
|
Neoplastic Process
|
59
|
9
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
LYMPHOPROLIFERATIVE SYNDROME 3
|
disease |
|
Disease or Syndrome
|
2
|
3
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Variable expressivity
|
phenotype |
|
Finding
|
319
|
|
0.100 |
None |
|
0 |
|
|
|
Persistent EBV viremia
|
phenotype |
|
Finding
|
1
|
|
0.100 |
None |
|
0 |
|
|
|
Decreased antibody level in blood
|
phenotype |
|
Finding
|
75
|
5
|
0.100 |
None |
|
0 |
|
|
|
Arteriosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2006
|
267
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Atherosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2044
|
281
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Macular dystrophy, corneal type 1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases
|
Disease or Syndrome
|
100
|
54
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Hyper-IgM Immunodeficiency Syndrome, Type 1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
33
|
22
|
0.030 |
None |
1.000 |
3 |
|
1998 |
2009 |
Chronic granulomatous disease
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
105
|
23
|
0.020 |
None |
1.000 |
2 |
|
2006 |
2012 |
Wiskott-Aldrich Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
95
|
34
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Autoimmune Lymphoproliferative Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
65
|
22
|
0.010 |
None |
< 0.001 |
1 |
|
2014 |
2014 |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
11
|
6
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
DiGeorge Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Endocrine System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
111
|
7
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Hereditary hemochromatosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
254
|
56
|
0.010 |
None |
< 0.001 |
1 |
|
2010 |
2010 |
Combined immunodeficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases
|
Disease or Syndrome
|
86
|
11
|
0.310 |
strong |
1.000 |
2 |
|
2013 |
2015 |